Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-24 @ 7:35 PM
NCT ID:
NCT00276003
Eligibility Criteria:
Inclusion Criteria:
1. Patients with a histologic diagnosis of non-HIV related B-cell NHL or Hodgkins disease are eligible.
2. Patients should have documented evidence of refractory or relapsed NHL or Hodgkins disease for inclusion.
3. Patient should have received 1 or more prior chemotherapeutic regimens for relapse, and should have completed last course of treatment at least 3 weeks prior to enrollment.
4. The patient must have bidimensionally measurable or evaluable disease.
5. Age \> 18 years.
6. ECOG Performance status \< 2
7. Informed consent.
8. ANC \> 1.5, platelet count \> 100K, creatinine\< 2.0, bilirubin \< 3
9. Female patients must have a negative pregnancy test.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00276003
Study Brief:
Protocol Section:
NCT00276003